Association between COVID-19 vaccines and paediatric safety outcomes in children and adolescents aged 5-19 years in the Nordic countries: Myocarditis, pericarditis and thromboembolic events

First published 04/10/2022

Last updated 02/07/2024

EU PAS number:

EUPAS48979

Study

Finalised

Documents

Study protocol

Initial protocol

EMACVS_STUDYPROTOCOL031022

English (1.39 MB - PDF)View document

Updated protocol

EMACVS_STUDYPROTOCOL_I_071122

First published: 22/02/2024

English (1022.51 KB - PDF)View document

Study results

EMACVS_ROC09_STUDYREPORT_I_revision_160223_clean

English (3.11 MB - PDF)View document

Study report

EMACVS_ROC09_STUDY_REPORT_II_29042023

English (1.88 MB - PDF)View document

Other information

Study, other information

EMA_CSV_STUDYPROTOCOL_II_131222_revision

English (1.02 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs